| telangiectatic cancer | A cancer with numerous dilated capillaries and "lakes" of blood within relatively large endothelium-lined channels. (05 Mar 2000) |
|---|
| telangiectatic | Relating to or marked by telangiectasia. (05 Mar 2000) |
|---|---|
| telangiectatic angioma | <tumour> Angioma composed of dilated vessels. Angioma venosum racemosum, tortuous swelling caused by varicosities of superficial veins. Venous angioma, vascular anomaly composed of anomalous veins. (05 Mar 2000) |
| telangiectatic fibroma | <tumour> A benign neoplasm of fibrous tissue in which there are numerous, small and large, frequently dilated, vascular channels. Synonym: angiofibroma. (05 Mar 2000) |
| telangiectatic glioma | <tumour> Glioma telangiectodes, a glioma in which the stroma has numerous, conspicuous, frequently dilated small blood vessels and capillaries, as well as large, endothelium-rimmed lakes of blood. (05 Mar 2000) |
| telangiectatic lipoma | A benign neoplasm composed of a mixture of adipose tissue and blood vessels. (12 Dec 1998) |
| telangiectatic osteogenic sarcoma | <tumour> A lytic cystic variant of osteogenic sarcoma composed of aneurysmal blood-filled spaces lined by sarcoma cells producing osteoid. (05 Mar 2000) |
| telangiectatic wart | A discrete, pink to red telangiectasia having a tendency to undergo secondary epithelial changes, including acanthosis and hyperkeratosis. An underlying vascular abnormality is present in many cases. The term angiokeratoma is applied to a number of quite distinct conditions which share a common clinical presentation with asymptomatic hyperkeratotic vascular skin lesions and a histological combination of superficial dermal vascular ectasia. (12 Dec 1998) |
| American Cancer Society | <address, organisation> American Cancer Society, National Headquarters, 1599 Clifton Road, NE, Atlanta, GA 30329 USA. Tel: 00 1 404 320-3333 (05 Feb 1998) |
| bladder cancer | The most common warning sign of bladder cancer is blood in the urine. The diagnosis of bladder cancer is supported by findings in the medical history and examination, blood, urine, and X-ray tests, and confirmed with a biopsy (usually during a cystoscope exam). Treatment of bladder cancer depends on the growth, size, and location of the tumour. (12 Dec 1998) |
| bladder cancer risks | Smoking is a major risk factor. Cigarette smokers develop bladder cancer 2-3 times more often than do nonsmokers. Quitting smoking reduces the risk of bladder cancer, lung cancer, several other types of cancer, and a number of other diseases as well. Workers in some occupations are at higher risk of developing bladder cancer because of exposure to carcinogens (cancer-causing substances) in the workplace. These workers include people in the rubber, chemical, and leather industries, as well as hairstylists, machinists, metal workers, printers, painters, textile workers, and truck drivers. (12 Dec 1998) |
| bone cancer | <oncology> A general term to imply malignant tumour growth in bone. (27 Sep 1997) |
| bovine cancer eye | A malignant squamous cell carcinoma of cattle, especially the Hereford breed, that originates in the conjunctival mucous membranes or the surrounding skin; it occurs principally in range cattle having unpigmented skin around the eye and living in regions of intense sunlight. (05 Mar 2000) |
| BRCA1 breast cancer susceptibility gene | This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer. (12 Dec 1998) |
| breast cancer | <oncology> The uncontrolled growth of malignant breast tissue. Breast cancer is currently the most common cancer in women and the leading cause of cancer-related death in the 15-54 age group. Strong risk factors include a prior history for breast cancer or a positive family history for breast cancer. Early detection is possible through the use of monthly breast self-examination, annual clinical exams and mammography. WWW: cancerNET document for patients WWW: cancerNET document for clinicians (05 Jan 1998) |
| breast cancer susceptibility genes | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. (12 Dec 1998) |